Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
European Addiction Research|July 3, 2003
Treatment of drug addiction in traumatised refugees. A case reportMichael Brune, Christian Haasen, Oktay Yagdiran, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|December 31, 2002
Belief systems as coping factors for traumatized refugees: a pilot studyMichael Brune, Christian Haasen, Michael Krausz, et al.Bioorganic & Medicinal Chemistry Letters|August 11, 2006
Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitorsVince S C Yeh, Jyoti R Patel, Hong Yong, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Discovery of orally active butyrolactam 11beta-HSD1 inhibitorsVince S C Yeh, Ravi Kurukulasuriya, Steven Fung, et al.Journal of Medicinal Chemistry|March 4, 2005
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesityAndrew J Souers, Ju Gao, Michael Brune, et al.Bioorganic & Medicinal Chemistry Letters|October 31, 2006
Adamantane sulfone and sulfonamide 11-beta-HSD1 InhibitorsBryan Sorensen, Martin Winn, Jeff Rohde, et al.Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonistsAnil Vasudevan, Andrew J Souers, Jennifer C Freeman, et al.Bioorganic & Medicinal Chemistry Letters|November 18, 2006
Discovery of adamantane ethers as inhibitors of 11beta-HSD-1: Synthesis and biological evaluationJyoti R Patel, Qi Shuai, Jurgen Dinges, et al.Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonistsAnil Vasudevan, Matthew J LaMarche, Christopher Blackburn, et al.Journal of Medicinal Chemistry|October 27, 2006
Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safetyJohn K Lynch, Jennifer C Freeman, Andrew S Judd, et al.Pageof 2